FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q64247473> ?p ?o ?g. }

• Q64247473 description "im Februar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
• Q64247473 description "wetenschappelijk artikel" @default.
• Q64247473 description "наукова стаття, опублікована в лютому 2019" @default.
• Q64247473 name "A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin conce" @default.
• Q64247473 name "A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin conce" @default.
• Q64247473 type Item @default.
• Q64247473 label "A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin conce" @default.
• Q64247473 label "A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin conce" @default.
• Q64247473 prefLabel "A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin conce" @default.
• Q64247473 prefLabel "A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin conce" @default.
• Q64247473 P1433 Q64247473-7244092D-2BD2-459B-B57A-B967EE6B796C @default.
• Q64247473 P1476 Q64247473-5F67E04A-9FA9-4BB1-88B1-8EDBA0DE5398 @default.
• Q64247473 P2093 Q64247473-015E22A3-6AAA-405F-9A0A-FA1AECED2BDA @default.
• Q64247473 P2093 Q64247473-11D1F0DB-DA88-4BF7-BA0A-3D1D9A7102E8 @default.
• Q64247473 P2093 Q64247473-28BA8645-52E0-4606-B407-0C90CAFFBBD6 @default.
• Q64247473 P2093 Q64247473-322C3A06-93A6-4574-9C8A-893F53151AF9 @default.
• Q64247473 P2093 Q64247473-4C19F71C-D76D-4AED-8EBF-F5A25A2D779C @default.
• Q64247473 P2093 Q64247473-4F138F77-1158-4726-810F-9A86C23510DC @default.
• Q64247473 P2093 Q64247473-69D1F7B3-9165-4984-8552-79DB9D35ECC7 @default.
• Q64247473 P2093 Q64247473-87AAC05B-D40C-480D-B14F-1E8AA86F46BA @default.
• Q64247473 P2093 Q64247473-946671F7-6240-4530-A4E7-B094E296AF62 @default.
• Q64247473 P2093 Q64247473-A2E119EB-A86A-4828-9F56-DFAC21E55BBF @default.
• Q64247473 P2860 Q64247473-00AE1E51-9647-4599-9016-1B561D88BD91 @default.
• Q64247473 P2860 Q64247473-049E8235-4FD4-4214-AF25-E2A6A95ACC2B @default.
• Q64247473 P2860 Q64247473-0A7EA5B2-42FD-42FB-BD2C-558F5C819ABD @default.
• Q64247473 P2860 Q64247473-128A68EE-0F45-4EC5-BB26-DA1C79E2FDD4 @default.
• Q64247473 P2860 Q64247473-17E9B1AE-E98C-43AE-98B1-14450BEE5E54 @default.
• Q64247473 P2860 Q64247473-1A6841DD-3CB5-4FB5-9860-002DA0A3839A @default.
• Q64247473 P2860 Q64247473-1DFC9D8A-34C1-4639-AA29-0EACD513180A @default.
• Q64247473 P2860 Q64247473-1F2B87BF-F731-4596-AB49-8356776DBE76 @default.
• Q64247473 P2860 Q64247473-1F6F6C38-4534-41AC-B1DB-663970E453C3 @default.
• Q64247473 P2860 Q64247473-212D158A-0A58-4438-9BC0-77F0D2A5BC08 @default.
• Q64247473 P2860 Q64247473-248E2E4A-3E83-4948-B098-0FFDF1467E01 @default.
• Q64247473 P2860 Q64247473-274868B4-E128-4EF5-8EDF-8574CFA8AB0B @default.
• Q64247473 P2860 Q64247473-34784D69-FDD5-4CF9-94A3-456DC4972208 @default.
• Q64247473 P2860 Q64247473-6B84F4D9-6F3D-4E6F-ADFC-4BF74310B721 @default.
• Q64247473 P2860 Q64247473-71B23988-2163-4D7E-B328-3646A9D49F23 @default.
• Q64247473 P2860 Q64247473-774DBD4A-EC75-442D-ACDB-4755EA29010A @default.
• Q64247473 P2860 Q64247473-7B1E0A99-1813-4246-84AA-A62723AF4144 @default.
• Q64247473 P2860 Q64247473-8A870D3F-D1A2-4ABA-9545-9B9AC3BA7803 @default.
• Q64247473 P2860 Q64247473-980783CE-6CCF-44AC-9535-7DD23E578209 @default.
• Q64247473 P2860 Q64247473-A2825D1E-7136-4882-AAB3-70A46C4EDD74 @default.
• Q64247473 P2860 Q64247473-A6054D45-E2A2-4900-B753-38DE17481975 @default.
• Q64247473 P2860 Q64247473-BDF5121B-AD37-4229-9547-9C9ABB3BB508 @default.
• Q64247473 P2860 Q64247473-CA6F793D-5856-47F7-A7CA-6CB5FCD21329 @default.
• Q64247473 P2860 Q64247473-CA768792-A7EC-424D-84C3-941DC9D8D18F @default.
• Q64247473 P2860 Q64247473-CCC30946-4398-4EE7-9B3F-65ABCA8CA075 @default.
• Q64247473 P2860 Q64247473-CE1949C9-D17F-4D65-B1C9-1D9F550F4D83 @default.
• Q64247473 P2860 Q64247473-CE5F8598-D655-4F68-99D3-BD527B399D9C @default.
• Q64247473 P2860 Q64247473-D0961401-7187-4139-8D97-515B470995F8 @default.
• Q64247473 P2860 Q64247473-D47B074B-4130-4B11-A9B2-8482B36C9D4E @default.
• Q64247473 P2860 Q64247473-D8F71C09-8619-49FC-8663-0AC45D47EFBB @default.
• Q64247473 P2860 Q64247473-E6A29188-F4DB-4538-B020-052184657B99 @default.
• Q64247473 P2860 Q64247473-E6E8C3EC-E112-4F3D-BA58-058B9D6C078B @default.
• Q64247473 P2860 Q64247473-F758742D-7948-4208-B2BA-25F0C69B7B7E @default.
• Q64247473 P2860 Q64247473-FCC5465F-91AE-464D-AFA9-EE6AA71EC178 @default.
• Q64247473 P304 Q64247473-6AF52155-045B-4ECC-AB1E-38637A08C29A @default.
• Q64247473 P31 Q64247473-3D3596C7-F285-4EB7-B104-C1CD22633418 @default.
• Q64247473 P356 Q64247473-097BA44A-5B43-4765-8A18-FC2B006E72E9 @default.
• Q64247473 P407 Q64247473-832E3F0F-5184-44C9-BC84-9693943310E2 @default.
• Q64247473 P433 Q64247473-78A68CF1-108E-47AA-893B-53F52BE6F234 @default.
• Q64247473 P478 Q64247473-2E34B466-B105-4ACD-91DB-4F3C93DF3B3F @default.
• Q64247473 P577 Q64247473-B61C2008-4428-4315-AA1B-7A524A0016C3 @default.
• Q64247473 P698 Q64247473-EA84484B-8A4F-4521-B549-C112D0F43ED0 @default.
• Q64247473 P921 Q64247473-1FD87975-4C85-4236-BE17-6F75C3A9024B @default.
• Q64247473 P921 Q64247473-804BA132-96EC-4045-A8B9-455C9C6C318C @default.
• Q64247473 P921 Q64247473-D7224836-8F55-4253-B8EE-EF141BB06988 @default.
• Q64247473 P921 Q64247473-DF92FA27-54E7-4561-A074-1E3F82A6C096 @default.
• Q64247473 P932 Q64247473-A124822D-1C7E-4E31-B50C-8862B1D60D36 @default.
• Q64247473 P356 BMJOPEN-2018-024475 @default.
• Q64247473 P698 30782906 @default.
• Q64247473 P1433 Q17003470 @default.
• Q64247473 P1476 "A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin conce" @default.
• Q64247473 P2093 "Alexandre Mebazaa" @default.
• Q64247473 P2093 "Alice Blet" @default.
• Q64247473 P2093 "Christopher Geven" @default.
• Q64247473 P2093 "Gernot Marx" @default.
• Q64247473 P2093 "Jens Zimmermann" @default.
• Q64247473 P2093 "Matthijs Kox" @default.
• Q64247473 P2093 "Oliver Hartmann" @default.
• Q64247473 P2093 "Paul Scigalla" @default.
• Q64247473 P2093 "Peter Pickkers" @default.
• Q64247473 P2093 "Pierre-François Laterre" @default.
• Q64247473 P2860 Q26746260 @default.
• Q64247473 P2860 Q26749027 @default.
• Q64247473 P2860 Q26768286 @default.
• Q64247473 P2860 Q28300913 @default.
• Q64247473 P2860 Q33749965 @default.
• Q64247473 P2860 Q33750991 @default.
• Q64247473 P2860 Q34436905 @default.
• Q64247473 P2860 Q35559489 @default.
• Q64247473 P2860 Q36700440 @default.
• Q64247473 P2860 Q37585835 @default.
• Q64247473 P2860 Q38433744 @default.
• Q64247473 P2860 Q38730216 @default.
• Q64247473 P2860 Q39125676 @default.
• Q64247473 P2860 Q39615420 @default.
• Q64247473 P2860 Q40491993 @default.
• Q64247473 P2860 Q42331372 @default.
• Q64247473 P2860 Q42381904 @default.

• next